{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:46:10Z","timestamp":1784583970752,"version":"3.55.0"},"reference-count":26,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Priapism is a condition characterized by a prolonged erection lasting over four hours, either independent of or following sexual stimulation. The primary treatment goal for ischemic and non-ischemic priapism is timely and appropriate intervention in order to preserve erectile function and penile length. This study aims to evaluate the management of recurrent ischemic priapism in sickle cell disease (SCD) patients in an endemic region and compare it with ischemic priapism of other etiologies. Materials and Methods: Patients admitted to our hospital with a diagnosis of priapism between January 2010 and June 2024 were retrospectively reviewed. The patients were divided into two groups: ischemic priapism due to SCD and ischemic priapism due to other etiologies. Patient characteristics, treatment management, and the need for penile prosthesis (PP) were compared. Results: A total of 40 ischemic priapism patients were included in the study; 20 of them had SCD and the other 20 had priapism cases due to different etiologies. In the SCD priapism group, the rate of comorbidity and previous history of priapism were significantly (p &lt; 0.05) higher than in the other etiologies of priapism group. Similarly, in the SCD priapism group, the hospital admission time and the rate of fibrosis findings in MRI (magnetic resonance imaging) were significantly (p &lt; 0.05) higher than in the other priapism groups. The PP implantation rate in the SCD priapism group was found to be significantly (p &lt; 0.05) higher than in the other priapism group. Conclusions: This study highlights the importance of early intervention and patient awareness in SCD-related ischemic priapism, recommending educational programs to improve symptom recognition and prevent complications.<\/jats:p>","DOI":"10.3390\/medicina61040658","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T04:33:43Z","timestamp":1743654823000},"page":"658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Management of Ischemic Priapism Due to Sickle Cell Disease and Other Etiologies: Treatment Strategies and Indications for Penile Prosthesis Implantation in an Endemic Region"],"prefix":"10.3390","volume":"61","author":[{"given":"Eser","family":"\u00d6rdek","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-5428","authenticated-orcid":false,"given":"Sad\u0131k","family":"G\u00f6r\u00fcr","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-3317","authenticated-orcid":false,"given":"Fatih","family":"G\u00f6kalp","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duran","family":"Kuru","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-8944","authenticated-orcid":false,"given":"Ferhat","family":"U\u00e7urmak","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay 31060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"Members of the Erectile Dysfunction Guideline Update Panel; Americal Urological Association. American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3324\/haematol.2011.055202","article-title":"Hemoglobin sickle cell disease complications: A clinical study of 179 cases","volume":"97","author":"Lionnet","year":"2012","journal-title":"Haematologica"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology. European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: Pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris","year":"2020","journal-title":"Blood Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1756287214542096","article-title":"Management of priapism: An update for clinicians","volume":"6","author":"Levey","year":"2014","journal-title":"Ther. Adv. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sxmr.2019.01.001","article-title":"Management of Priapism: A Contemporary Review","volume":"8","author":"Mishra","year":"2020","journal-title":"Sex. Med. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euf.2022.11.005","article-title":"Insertion of Penile Implants in Patients with Priapism: When Is the Right Time?","volume":"9","author":"Muneer","year":"2023","journal-title":"Eur. Urol. Focus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/JU.0000000000002236","article-title":"Acute Ischemic Priapism: An AUA\/SMSNA Guideline","volume":"206","author":"Bivalacqua","year":"2021","journal-title":"J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/hematology.2022000380","article-title":"Epidemiology and treatment of priapism in sickle cell disease","volume":"2022","author":"Idris","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/TME.0000000000000494","article-title":"Priapism in a Young Adult With Sickle Cell Disease","volume":"46","author":"Frank","year":"2024","journal-title":"Adv. Emerg. Nurs. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2014An international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","article-title":"Hemolysis-associated priapism in sickle cell disease","volume":"106","author":"Nolan","year":"2005","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1182\/bloodadvances.2022007285","article-title":"Incidence and predictors of priapism events in sickle cell anemia: A diary-based analysis","volume":"6","author":"Idris","year":"2022","journal-title":"Blood Adv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow-up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pereira, D.A., Pereira, D.A., da Silva Pereira, P., Silveira, T.H.R., Calmasini, F.B., Reis, L.O., Costa, F.F., and Silva, F.H. (2023). Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0292706"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JU.0000000000002767","article-title":"The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA\/SMSNA Guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J. Urol."},{"key":"ref_20","unstructured":"Silberman, M., Stormont, G., Leslie, S.W., and Hu, E.W. (2025). Priapism. [Updated 2023 May 30]. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/andr.12408","article-title":"Preliminary results of a new tool to evaluate cavernous body fibrosis following radical prostatectomy: Penile elastography","volume":"5","author":"Hamidi","year":"2017","journal-title":"Andrology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/aja202147","article-title":"Experimental investigation of early assessment of corpora cavernosa fibrosis with two-dimensional shear wave elastography","volume":"24","author":"Yu","year":"2022","journal-title":"Asian J. Androl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: Targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1464-410X.2005.05907.x","article-title":"Outcome of penile prosthesis implantation for treating erectile dysfunction: Experience with 504 procedures","volume":"97","author":"Minervini","year":"2006","journal-title":"BJU Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/2090598X.2022.2135290","article-title":"Early versus delayed penile prosthesis insertion for refractory ischemic priapism","volume":"21","author":"Salman","year":"2022","journal-title":"Arab. J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NAJ.0000559779.40570.2c","article-title":"CE: Understanding the Complications of Sickle Cell Disease","volume":"119","author":"Tanabe","year":"2019","journal-title":"Am. J. Nurs."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:09:05Z","timestamp":1760029745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["medicina61040658"],"URL":"https:\/\/doi.org\/10.3390\/medicina61040658","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}